AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value
Medtronic AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value decreased by 1.4% to $749.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.1%, from $852.00M to $749.00M. Over 4 years (FY 2021 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value shows a downward trend with a -3.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A high value may indicate short-term market volatility affecting the portfolio, while a low value suggests portfolio stability.
Detailed definition
The fair value of debt securities classified as available-for-sale or trading that are currently in an unrealized loss p...
Peer comparison
Commonly used in financial services to assess the duration and severity of investment portfolio impairments.
afs_debt_securities_unrealized_loss_less_12m_fvHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $946.00M | $976.00M | $0.00 | $0.00 | $222.00M | $243.00M | $207.00M | $292.00M | $401.00M | $488.00M | $528.00M | $600.00M | $838.00M | $803.00M | $782.00M | $852.00M | $814.00M | $735.00M | $760.00M | $749.00M |
| QoQ Change | — | +3.2% | -100.0% | — | — | +9.5% | -14.8% | +41.1% | +37.3% | +21.7% | +8.2% | +13.6% | +39.7% | -4.2% | -2.6% | +9.0% | -4.5% | -9.7% | +3.4% | -1.4% |
| YoY Change | — | — | — | — | -76.5% | -75.1% | — | — | +80.6% | +100.8% | +155.1% | +105.5% | +109.0% | +64.5% | +48.1% | +42.0% | -2.9% | -8.5% | -2.8% | -12.1% |
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is Medtronic's afs and trading securities - unrealized loss position (<12 months) fair value?
- Medtronic (MDT) reported afs and trading securities - unrealized loss position (<12 months) fair value of $749.00M in Q4 2025.
- How has Medtronic's afs and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
- Medtronic's afs and trading securities - unrealized loss position (<12 months) fair value decreased by 12.1% year-over-year, from $852.00M to $749.00M.
- What is the long-term trend for Medtronic's afs and trading securities - unrealized loss position (<12 months) fair value?
- Over 4 years (2021 to 2025), Medtronic's afs and trading securities - unrealized loss position (<12 months) fair value has grown at a -3.7% compound annual growth rate (CAGR), from $946.00M to $814.00M.
- What does afs and trading securities - unrealized loss position (<12 months) fair value mean?
- The current market value of debt investments that have been worth less than their cost for less than a year.